L Carlsson, D Chartier, S Nattel - Journal of cardiovascular pharmacology, 2006 - journals.lww.com Skip Navigation Links Home > January 2006 - Volume 47 - Issue 1 >
Characterization of the In Vivo and In Vitro Electrophysiolo... ... From the
*AstraZeneca R&D Mölndal, Integrative Pharmacology, Sweden; and ... Cited by 27 - Related articles - BL Direct - All 5 versions
G Boriani, I Diemberger, M Biffi, G … - International Journal of Clinical Practice, 2007 - phx1.medscape.com Despite the results of Atrial Fibrillation Follow-up Investigation of Rhythm
Management and Rate Control versus Electrical Cardioversion for Persistent
Atrial Fibrillation trials, which favour a general shift in atrial ... Cited by 6 - Related articles - BL Direct - All 8 versions
- ►nih.gov V Essebag, MR Reynolds, T Hadjis, R Lemery … - Archives of internal medicine, 2007 - archinte.highwire.org Background Amiodarone use was associated with an increased need for pacemaker
insertion in a retrospective study of patients with atrial fibrillation (AF) and
prior myocardial infarction. The aims of this study were to determine ... Cited by 2 - Related articles - BL Direct - All 6 versions
AE Saltman - Seminars in Thoracic and Cardiovascular Surgery, 2007 - Elsevier Atrial fibrillation (AF) has attracted much attention over the last decade, in
both electrophysiologic and cardiac surgical circles. As pharmacologic solutions
have proven largely inadequate at converting patients to sinus rhythm 1 and ... Related articles - All 10 versions
CW Siu, HF Tse - Therapy, 2005 - Future Medicine Atrial fibrillation (AF) is the most commonly occurring cardiac arrhythmia. Due
to the low clinical efficacy of current antiarrhythmic agents, various
nonpharmacologic approaches including catheter ablation, permanent cardiac ... Related articles - BL Direct - All 5 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
B Olshansky - Current Treatment Options in Cardiovascular Medicine, 2005 - Springer SYMPTOMS AND AF Symptoms vary by AF type, patient age, and underlying heart
disease [7]. In elderly patients, excess fatigue is common. In younger patients,
palpitations and dyspnea prevail. Symptoms are the primary reason to treat ... Related articles - BL Direct - All 3 versions
NM Allen LaPointe, JL Sun, S Kaplan, P d' … - The American Journal of Cardiology, 2008 - Elsevier Little is presently known regarding whether a rhythm-control or a rate-control
strategy is more frequently used in patients hospitalized for atrial
fibrillation (AF). This study was conducted to assess patient and physician ... Related articles - BL Direct - All 3 versions
